2015/09/30
Medigen Vaccine Biologics CO. issued 20,000,000 new shares of the common stock for seasoned equity offering
2015/08/30
Medigen Vaccine Biologics CO. (MVC) submitted request for seasoned equity offering on September 14th , and was approved by Taiwan Financial Supervisory Commission on September 23rd . MVC issued 20,000,000 new shares with par value of $10 TWD and pric
2015/08/20
Medigen Vaccine Biologics Co. listed on Taiwan OTC stock market (emerging stock market) on Aug 6th, 2015.
2015/06/11
Medigen Vaccine Biologics Corporation (MVC) has obtained the approval to go public on June 11, 2015.
2014/12/11
Entering of Phase II Study for Enterovirus Vaccine
2014/04/25
MVC signed the licensing agreement with NHRI for H7N9 vaccine.
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree